Request Deal Involvement

RA Capital Management led a $60m Series A round in Lusaris Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

ScientPR

pr advisors

ScientPR

or

Principals

LUSARIS THERAPEUTICS

target

LUSARIS THERAPEUTICS

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

BOXER CAPITAL

bidder

BOXER CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - RA Capital Management led a $60m Series A round in Lusaris Therapeutics.